NVNO today
$6.52+$0.07 (+1.09%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minBullish
5 minConsolidating
Daily trend turns up above $12.49
Key levels
Resistance$8.77
Resistance$7.74
Latest news & SEC filings
ProductenVVeno Medical to present enVVe System at TCT 2025 symposium
EarningsenVVeno Medical reports Q3 2026 results, readies TAVVE study enrollment
ProductenVVeno Medical says first stage of U.S. enVVe venous valve study to start before year end
All NVNO news →About enVVeno Medical
enVVeno Medical is a medical device company developing tissue-based bioprosthetic solutions for venous disease. Its lead product candidate is the enVVe System, a transcatheter-delivered replacement venous valve for severe chronic venous insufficiency of the deep leg veins. The company also developed the surgical VenoValve, which the FDA declined to approve. It operates a manufacturing facility in Irvine, California, and its products are intended for patients with deep venous CVI.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
enVVeno Medical Corp (NVNO)
What Is the Price Target for NVNO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NVNO a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NVNO.
Start Free Trial →Is NVNO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$62.58
12
Moat Score
NONE
1/9
Piotroski Score
-8.4
Altman Z-Score
What Is Smart Money Doing with NVNO?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Duhay Francis | director | Sale | 140 | $1K | Jun 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NVNO Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
25.76%
FCF Growth YoY
7.7%
Revenue Trend
UNKNOWN
Dark Pool Trades for NVNO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NVNO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:02:08 | $7.17 | 2,010 | $$14K | BUY |
| 15:04:29 | $7.21 | 1,500 | $$11K | BUY |
| 15:01:41 | $7.21 | 1,000 | $$7K | BUY |
| 14:11:19 | $6.96 | 1,050 | $$7K | SELL |
| 14:09:32 | $6.90 | 1,500 | $$10K | BUY |
5 dark pool trades shown · $$50K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for enVVeno Medical Corp (NVNO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NVNO — frequently asked questions
What is NVNO stock price today?
enVVeno Medical Corp (NVNO) is at $6.52, up 1.09% (+$0.07) at the Nov 11, 2026 close.
Why is NVNO stock moving today?
Latest NVNO news — Nov 3, 2026: enVVeno Medical to present enVVe System at TCT 2025 symposium · Oct 30, 2026: enVVeno Medical reports Q3 2026 results, readies TAVVE study enrollment
Did NVNO beat earnings?
NVNO last reported on Oct 30, 2026: EPS -$6.29 vs -$3.27 expected — a miss of 92.4%.
Does NVNO pay a dividend?
NVNO does not currently pay a dividend.
What are NVNO support and resistance levels?
Resistance: $7.74, $8.77, $9.58.
What are insiders doing with NVNO?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on NVNO?
Nov 3, 2026: enVVeno Medical to present enVVe System at TCT 2025 symposium · Oct 30, 2026: enVVeno Medical reports Q3 2026 results, readies TAVVE study enrollment · Oct 30, 2026: enVVeno Medical says first stage of U.S. enVVe venous valve study to start before year end